Mathijs C Bunck

12PUBLICATIONS
10CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Characterisation of biological macromoleculesPharmacogenomicsClinical pharmacology and therapeutics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Feb 11, 2025
Single incretin receptor knockout mice do not compensate by increasing glucose-stimulated secretion of the remaining incretin hormone.

Katrine D Galsgaard, Jon Vergara, Sara L Jepsen

|Jan 31, 2024
In Vivo Inhibition of Dipeptidyl Peptidase 4 Allows Measurement of GLP-1 Secretion in Mice.

Mark M Smits, Katrine D Galsgaard, Sara Lind Jepsen

|Jul 24, 2023
Endogenous glucagon-like peptide (GLP)-1 as alternative for GLP-1 receptor agonists: Could this work and how?

Mark M Smits, Jens J Holst

|Sep 28, 2021
Postprandial renal haemodynamic effects of the dipeptidyl peptidase-4 inhibitor linagliptin versus the sulphonylurea glimepiride in adults with type 2 diabetes (RENALIS): A predefined substudy of a randomized, double-blind trial.

Marcel H A Muskiet, Lennart Tonneijck, Mark M Smits

|Sep 09, 2020
Effects of DPP-4 Inhibitor Linagliptin Versus Sulfonylurea Glimepiride as Add-on to Metformin on Renal Physiology in Overweight Patients With Type 2 Diabetes (RENALIS): A Randomized, Double-Blind Trial.

Marcel H A Muskiet, Lennart Tonneijck, Mark M Smits

|Jun 02, 2020
Effects of dipeptidyl peptidase-4 inhibitor linagliptin versus sulphonylurea glimepiride on systemic haemodynamics in overweight patients with type 2 diabetes: A secondary analysis of an 8-week, randomized, controlled, double-blind trial.

Jordan Kraaijenhof, Marcel H A Muskiet, Lennart Tonneijck

Pageof 2

Frequent Collaborators

4 joint publications

Mark H H Kramer

4 joint publications

Jens J Holst

2 joint publications

Lennart Tonneijck

2 joint publications

D Margriet Ouwens